Traws Pharma Falls After FDA Puts Flu Drug Application on Clinical Hold

Traws Pharma stock dropped 23% today after the FDA placed a clinical hold on its monthly flu prevention pill due to mutagenicity concerns. Positive COVID drug results couldn’t offset the news.

Traws Pharma Falls After FDA Puts Flu Drug Application on Clinical Hold
Credit: Traws Pharma
Already have an account? Sign in.